Scholarly Works - Preprints
Preprint
·
November 5, 2025
Abstract
Triple-negative breast cancer (TNBC) is a major cause of cancer mortality, with distant metastases presenting a significant clinical challenge. While epigenetic mechanisms like DNA methylation a ...
Full text
Cite
Preprint
·
2025
Abstract Background Management of axillary lymph node (LN) disease in breast cancer (BC) is evolving, with declining use of axillary lymph node dissection. Consequently, prognostic information from nodal assessment is becoming limited. ...
Full text
Cite
Preprint
·
2023
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype that exhibits a high incidence of distant metastases and lacks targeted therapeutic options. Here we explored how the epigenome may contribute to matrix metalloprotease (MM ...
Full text
Cite
Preprint
·
2021
AbstractPurpose: Omission of axillary lymph node dissection (ALND) is considered for patients with sentinel lymph node-positive (SLN+) breast cancer, but ALND remains the standard of care for clinically node-positive (cN+) ...
Full text
Cite